Jim Cramer is flagging an Amgen drug that Wall Street has largely ignored, and he thinks the cardiovascular opportunity ...

Donald Trump has been accused of dozing off again during a White House healthcare briefing, RadarOnline. com can reveal.

Key context: The Trump administration is also touting an effort known as the Medicare GLP-1 Bridge Program that connects ...

Under the deals, the drug makers would charge Americans no more than the lowest price paid in other rich countries.

From today, the Australian government will expand Pharmaceutical Benefits Scheme (PBS) access to the drug Keytruda for three ...

The deal gives the Pentagon a 35% ownership stake of the private company being created, and the State Department will get a ...

Donald Trump has been accused of dozing off again during a White House healthcare briefing where he was praised for making ...

President Trump vowed better access to GLP-1 weight loss drugs for Medicaid recipients. But thus far only Indiana has ...

U.S. President Donald Trump announced a new round of drug-pricing agreements with international pharmaceutical companies and ...

Trump administration announces drug pricing deals with CSL, Astellas and others - Nation and World News | Hawaii ...

Oz, the administrator of the Centers for Medicare and Medicaid Services, and Kennedy Jr., the secretary of Health and Human ...

Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to meaningfully impact drugmaker profits.